New hope for tough cancers: experimental drug TB511 enters human trials
Disease control
Not yet recruiting
This early-phase trial tests a new drug called TB511 in people with advanced solid tumors (lung, prostate, colorectal, or liver cancer) that have stopped responding to standard care. The study has two parts: first, finding the safest dose of TB511 alone; second, testing TB511 com…
Phase: PHASE1, PHASE2 • Sponsor: Twinpig Biolab, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC